IP Library Granted Patent US 10,975,033
Granted Patent B2
US 10,975,033 · App. 14/232,615 · Granted Apr 13, 2021

Methods for treating inflammation and hypertension with γ-ketoaldehyde skavengers

Inventors: L. Jackson Roberts, II (Gallatin, TN); Venkataraman Amarnath (Nashville, TN); David G. Harrison (Atlanta, GA); Annet Kirabo (Nashville, TN)
Assignee: Vanderbilt University
C07D213/65A61K31/137A61K31/44C07C215/50C07C217/58
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,975,033
App. No.
14/232,615
Granted
Apr 13, 2021
Kind
B2
Abstract

A method of treating at least one of inflammation, psoriasis, and/or hypertension comprising administering to a patient in need there of an effective gamma-ketoaldehyde scavenging amount of a gamma-ketoaldehyde scavenging compound.

Claims (10)

1. A method of treating or ameliorating an isoprostane induced inflammatory autoimmune response, comprising administering a gamma-ketoaldehyde scavenging effective amount to a patient in need thereof a compound of the following formula:

and stereoisomers and pharmaceutically acceptable salts thereof,

wherein the inflammatory autoimmune response includes at least one of hypertension, psoriasis, or edema.

2. A method of treating hypertension, comprising administering to a patient in need thereof an effective amount of a compound of the following formula:

and stereoisomers and pharmaceutically acceptable salts thereof.

3. A method of treating hypertension, comprising co-administering to a patient in need thereof a gamma-ketoaldehyde scavenging effective amount of a compound of the following formula:

and stereoisomers and pharmaceutically acceptable salts thereof, with an additional pharmaceutical agent known for at least one of treating inflammation, treating an isoprostane-induced autoimmune response, and reducing hypertension.

4. The method of claim 1 , wherein the co-administration is separate compositions given at the same time or at different times.

5. A method of treating psoriasis, comprising administering to a patient in need thereof an effective amount of a compound of the following formula:

and stereoisomers and pharmaceutically acceptable salts thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2017
From: KIRABO, ANNET
To: VANDERBILT UNIVERSITY
Reel/Frame 041577/0697 →
CONFIRMATORY LICENSE Recorded Oct 19, 2015
From: VANDERBILT UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036823/0891 →
Continuity (2)
Provisional Application 61506848 · Jul 12, 2011
Related Publication 20140256774A1 · Sep 11, 2014